CONMED Corp
CNMD- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0000816956
No open-market purchases or sales by CONMED Corp insiders were filed in the last 90 days; 246 institutions reported holding it in 13F filings for Q2 2026, worth $1.12B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by CONMED Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for CONMED Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kelderman Kim | Director | 500 | Sep 10, 2026 | 2 |
| Gallagher John E | Executive Vice President & CFO | – | Jul 17, 2026 | 1 |
| Martin Celine Christine | Director | – | Jul 2, 2026 | 1 |
| Mirviss Jeffrey B. | Director | – | Jul 2, 2026 | 1 |
| Bronson David M | Director | 17,909 | Jun 3, 2026 | 1 |
| Farkas Charles | Director | 15,527 | Jun 3, 2026 | 1 |
| Kaye Mark | Director | 820 | Jun 3, 2026 | 2 |
| Schwarzentraub Barbara J | Director | 5,012 | Jun 3, 2026 | 1 |
| Council LaVerne H | Director | 4,716 | Jun 3, 2026 | 1 |
| Beyer Pat | President & CEO | 10,807 | Apr 2, 2026 | 2 |
| Shagory Peter K | EVP, STRAT & CORP DEVT | 3,897 | Mar 18, 2026 | 1 |
| Lalomia Brent | Executive VP RA, QA | 915 | Mar 18, 2026 | 2 |
| Ferrell John D. | Executive Vice President - HR | 702 | Mar 18, 2026 | 1 |
| Foust Hollie K | General Counsel & Corp Sec | 2,886 | Mar 18, 2026 | 2 |
| Schabacker Matthew | VP GM Advanced Surgical | – | Mar 18, 2026 | 1 |
| Pelletier Johonna Marie | Treasurer and VP, Tax | 1,317 | Mar 4, 2026 | 1 |
| Moller Andrew James | VP Corporate Controller | – | Mar 4, 2026 | 1 |
| Glaze Richard | Chief Information Officer | 0 | Nov 24, 2025 | 2 |
| Garner Todd W | Executive Vice President & CFO | 1,836 | Nov 7, 2025 | 2 |
| Concannon Brian | Director | 10,116 | Jun 4, 2025 | 0 |
| Aronson Martha Goldberg | Director | 12,391 | Jun 4, 2025 | 0 |
| Workman John L | Director | 20,891 | May 21, 2025 | 0 |
| Epinette Stephan | VP GM International | – | May 15, 2025 | 0 |
| Clifford Edward A. | VP Global Manufacturing | 378 | Mar 5, 2025 | 0 |
| Hartman Curt R | President and CEO | 9,996 | Nov 8, 2024 | 0 |
| Peters Stanley W III | President AS and AET | 63 | Jun 17, 2024 | 0 |
| Lande Jerome J. | Director | 3,856 | Jun 4, 2024 | 0 |
| Cohen Heather L | EVP & Chief HR & Legal Officer | 35,992 | Apr 3, 2024 | 0 |
| Berge Terence M | VP-Corporate Controller | 1,004 | Mar 5, 2024 | 0 |
| Jonas Daniel S | Special Counsel & Corp Secy | 13,462 | May 2, 2023 | 0 |
| Peterson Jaclyn | VP of Mfg. & Adv. Engineering | 739 | Mar 3, 2023 | 0 |
| Tryniski Mark E | Director | 9,108 | Jun 3, 2022 | 0 |
| Kennedy John Jed | Group Executive Vice President | 9,855 | Mar 7, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2025 (view filing) | Aug 7 | 1 day | Garner Todd WExecutive Vice President & CFO | SSale | −598 | $52.45 | −$31.4K | −100.0%0 after | |
| Sep 15, 2025 (view filing) | Sep 12 | 3 days | Farkas CharlesDirector | SSale | −2.00K | $53.53 | −$107.1K | −11.9%14.9K after | 2 lots |
| Nov 7, 2025 (view filing) | Nov 6 | 1 day | Garner Todd WExecutive Vice President & CFO | SSale | −3.50K | $43.00 | −$150.5K | −65.6%1.84K after | 10b5-1 |
| Nov 24, 2025 (view filing) | Nov 21 | 3 days | Glaze RichardChief Information Officer | SSale | −257 | $41.21 | −$10.6K | −100.0%0 after | 10b5-1 |